Pearson, A. D., Gaspar, N., Janeway, K., Campbell-Hewson, Q., Lawlor, E. R., Copland, C., Karres, D., Norga, K., Benzaghou, F., Weiner, S., Weigel, B., Weiss, A. R., Strauss, S. J., Smith, M., Setty, B. A., Seibel, N., Scobie, N., Pappo, A., Okpara, C. E., Nysom, K., McDonough, J., Marshall, L. V., Ludwinski, D., Ligas, F., Lesa, G., Knudsen, S., Kauh, J., Hsieh, A., Heenen, D., Hawkins, D. S., Graham, A., Garmey, E., DuBois, S. G., Fox, E., Donoghue, M., de Rojas, T., Chung, J., Casanova, M., Brennan, B., Bishop, M., Buenger, V., Reaman, G., & Vassal, G. (2022). paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas. European journal of cancer, 173, 71–90. http://access.bl.uk/ark:/81055/vdc_100163062876.0x00002d